| P50 | author | Agnieszka Słowik | Q30437288 |
| | Joanna Pera | Q57981485 |
| | Andrzej Szczudlik | Q112114657 |
| P2093 | author name string | Dziedzic T | |
| | Gryz-Kurek EA | |
| P2860 | cites work | Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 |
| | Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses | Q31047774 |
| | Causes and mechanisms of hypoalbuminaemia | Q34283746 |
| | Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study | Q36244107 |
| | Association between inflammation and malnutrition as risk factors of cardiovascular disease | Q36345540 |
| | Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome | Q40672090 |
| | Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study | Q40678166 |
| | Multiple levels of regulation of the interleukin-6 system in stroke | Q42170532 |
| | Editorial comment--the MOST score: modifying the open-artery "good"-closed-artery "bad" approach to thrombolysis prognosis | Q42615383 |
| | The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results | Q42689955 |
| | Effect of malnutrition after acute stroke on clinical outcome | Q43994775 |
| | Nutritional status of patients hospitalised in Poland | Q45267842 |
| | When to measure lipid profile after stroke? | Q45282819 |
| | C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study | Q46128170 |
| | Influence of nutritional status on clinical outcome after acute stroke | Q47697593 |
| | Serum albumin level as a predictor of ischemic stroke outcome | Q47792477 |
| | The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis | Q48482907 |
| | Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window | Q49076970 |
| | Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. | Q53636243 |
| | Impact of Premorbid Undernutrition on Outcome in Stroke Patients | Q57198157 |
| | Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study | Q64135252 |
| | Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group | Q69911384 |
| | Serum albumin level and nosocomial pneumonia in stroke patients | Q83161218 |
| P433 | issue | 11 | |
| P304 | page(s) | 1318-1322 | |
| P577 | publication date | 2007-01-24 | |
| P1433 | published in | European Journal of Clinical Nutrition | Q15756702 |
| P1476 | title | Hypoalbuminemia in acute ischemic stroke patients: frequency and correlates. | |
| P478 | volume | 61 | |